Theme: To create global awareness and to share novel approaches on treating Liver and Pancreatic Diseases

Hepatology 2017

Hepatology 2017

About Conference

Conference Series LLC will be pleased to invite you to the 4th International Conference on Hepatology  to be held in beautiful city, Dubai, UAE during April 27-28, 2017. The conference highlights the theme “To create global awareness and to share novel approaches on treating Liver and Pancreatic Diseases”.

The conference proceedings include symposiums and workshops, keynote speeches, plenary talks, poster sessions and panel discussion on latest research developments in the field of Hepatology.

OMICS International organizes 300+ International Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific Societies and publishes 400+ Open Access Journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. - See more at: http://pancreas.conferenceseries.com/#sthash.Z11s31NP.dpuf

Conference Series LLC organizes 600+ International Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific Societies and publishes 400+ Open Access Journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Conference Opportunities

For Researchers and Faculty Members:

Speaker Presentations
Poster Display
Symposium hosting (4-5 member team)
Workshop organizing

For Universities, Associations & Societies:

Association Partnering
Collaboration proposals
Academic Partnering
Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
Student Attendee
Group registrations

For Business Delegates:

Speaker Presentations
Symposium hosting
Book Launch event
Networking opportunities
Audience participation

For Product Manufacturers:

Exhibitor and Vendor booths
Sponsorships opportunities
Product launch
Workshop organizing
Scientific Partnering
Marketing and Networking with clients

 





Session Tracks

Track 1: Inflammation and Immunology

The word hepatitis refers to liver inflammation. Liver inflammation is a response that happens when liver cells are assaulted by a disease causing microbe or substance.These functions include producing bile to separate sustenance into vitality; making basic substances, for example, hormones; cleaning poisons from the blood, including those from solution, liquor and medicates; and controlling fat stockpiling and cholesterol creation and discharge.

Relevant Conferences:

4th International Conference on Hepatology April 27-28, 2017 Dubai, UAE 11th Global Gastroenterologists Meeting June 12-13, 2017 Rome, Italy, 5th World Congress on Hepatitis and Liver Diseases August 10-12, 2017 London, UK, 12th Euro-Global Gastroenterology Conference September 11-12, 2017 Paris, France, 2nd International Conference on Pancreatic Disorders and Treatment September 14-15, 2017 Dallas, USA, International Conference on Digestive Diseases October 16-18, 2017 Chicago, USA, 10th Global Congress on Gastroenterology and Endoscopy October 30-November 01, 2017 Bangkok, Thailand, 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA, German Association for the Study of the Liver, January 19-21, 2017 Essen, Germany, 10th Paris Hepatitis Conference January 30-31, 2017 Paris, France, EASL HCC Summit, February 02-05, 2017 Geneva, Switzerland, Belgian Week of Gastroenterology February 09-11, 2017 Antwerp, Belgium, Asian Pacific Digestive Week, Japan Digestive Disease Week, Paris Hepatitis Conference, World Congress on Gastroenterology.

Track 2: Viral Hepatitis A and E

Hepatitis has been classified into four different types (Hepatitis A, B, C and E) but over two billions of individuals were infected with hepatitis B at some point in their life and around 350 million people are persistent carriers of the virus. With widespread vaccines and blood screening, the incidence of hepatitis B has been significantly decreased. But, hepatitis B and hepatitis C are accountable for up to 80% of liver cancer cases.

Relevant Conferences:

4th International Conference on Hepatology April 27-28, 2017 Dubai, UAE 11th Global Gastroenterologists Meeting June 12-13, 2017 Rome, Italy, 5th World Congress on Hepatitis and Liver Diseases August 10-12, 2017 London, UK, 12th Euro-Global Gastroenterology Conference September 11-12, 2017 Paris, France, 2nd International Conference on Pancreatic Disorders and Treatment September 14-15, 2017 Dallas, USA, International Conference on Digestive Diseases October 16-18, 2017 Chicago, USA, 10th Global Congress on Gastroenterology and Endoscopy October 30-November 01, 2017 Bangkok, Thailand, 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA, German Association for the Study of the Liver, January 19-21, 2017 Essen, Germany, 10th Paris Hepatitis Conference January 30-31, 2017 Paris, France, EASL HCC Summit, February 02-05, 2017 Geneva, Switzerland, Belgian Week of Gastroenterology February 09-11, 2017 Antwerp, Belgium, Asian Pacific Digestive Week, Japan Digestive Disease Week, Paris Hepatitis Conference, World Congress on Gastroenterology.

Track 3: Viral Hepatitis B and D

With widespread vaccines and blood screening, the incidence of hepatitis B has been significantly decreased. But, hepatitis B and hepatitis C are accountable for up to 80% of liver cancer cases.

Relevant Conferences:

4th International Conference on Hepatology April 27-28, 2017 Dubai, UAE 11th Global Gastroenterologists Meeting June 12-13, 2017 Rome, Italy, 5th World Congress on Hepatitis and Liver Diseases August 10-12, 2017 London, UK, 12th Euro-Global Gastroenterology Conference September 11-12, 2017 Paris, France, 2nd International Conference on Pancreatic Disorders and Treatment September 14-15, 2017 Dallas, USA, International Conference on Digestive Diseases October 16-18, 2017 Chicago, USA, 10th Global Congress on Gastroenterology and Endoscopy October 30-November 01, 2017 Bangkok, Thailand, 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA, German Association for the Study of the Liver, January 19-21, 2017 Essen, Germany, 10th Paris Hepatitis Conference January 30-31, 2017 Paris, France, EASL HCC Summit, February 02-05, 2017 Geneva, Switzerland, Belgian Week of Gastroenterology February 09-11, 2017 Antwerp, Belgium, Asian Pacific Digestive Week, Japan Digestive Disease Week, Paris Hepatitis Conference, World Congress on Gastroenterology.

Track 4: Viral Hepatitis C

A hepatitis C vaccine is capable of protecting against hepatitis C, is not available. No vaccine is currently available for hepatitis C but several vaccines are currently under development.

Relevant Conferences:

4th International Conference on Hepatology April 27-28, 2017 Dubai, UAE 11th Global Gastroenterologists Meeting June 12-13, 2017 Rome, Italy, 5th World Congress on Hepatitis and Liver Diseases August 10-12, 2017 London, UK, 12th Euro-Global Gastroenterology Conference September 11-12, 2017 Paris, France, 2nd International Conference on Pancreatic Disorders and Treatment September 14-15, 2017 Dallas, USA, International Conference on Digestive Diseases October 16-18, 2017 Chicago, USA, 10th Global Congress on Gastroenterology and Endoscopy October 30-November 01, 2017 Bangkok, Thailand, 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA, German Association for the Study of the Liver, January 19-21, 2017 Essen, Germany, 10th Paris Hepatitis Conference January 30-31, 2017 Paris, France, EASL HCC Summit, February 02-05, 2017 Geneva, Switzerland, Belgian Week of Gastroenterology February 09-11, 2017 Antwerp, Belgium, Asian Pacific Digestive Week, Japan Digestive Disease Week, Paris Hepatitis Conference, World Congress on Gastroenterology.

Track 5: Cirrhosis and Its Complications         

Liver disease can be due to genetic or caused by a variety of factors that damage the liver, such as virus’s infection and consumption of alcohol. Liver damage is also associated with Obesity. Over time, damage to the liver has results in scarring (Liver cirrhosis), this can lead to liver failure, a life-threatening diseases. Liver disease is one of the top 10 causes of death in USA. There are more than 100 liver diseases. Some of the most common liver diseases are as follow.

Relevant Conferences:

4th International Conference on Hepatology April 27-28, 2017 Dubai, UAE 11th Global Gastroenterologists Meeting June 12-13, 2017 Rome, Italy, 5th World Congress on Hepatitis and Liver Diseases August 10-12, 2017 London, UK, 12th Euro-Global Gastroenterology Conference September 11-12, 2017 Paris, France, 2nd International Conference on Pancreatic Disorders and Treatment September 14-15, 2017 Dallas, USA, International Conference on Digestive Diseases October 16-18, 2017 Chicago, USA, 10th Global Congress on Gastroenterology and Endoscopy October 30-November 01, 2017 Bangkok, Thailand, 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA, German Association for the Study of the Liver, January 19-21, 2017 Essen, Germany, 10th Paris Hepatitis Conference January 30-31, 2017 Paris, France, EASL HCC Summit, February 02-05, 2017 Geneva, Switzerland, Belgian Week of Gastroenterology February 09-11, 2017 Antwerp, Belgium, Asian Pacific Digestive Week, Japan Digestive Disease Week, Paris Hepatitis Conference, World Congress on Gastroenterology.

Track 6: Liver Transplantation and Surgery

Liver transplantation is a surgery to remove the diseased or injured liver and replace it with a whole new healthy liver or a segment of the liver from another/healthy person, who is called as a donor. People with acute or chronic liver failure undergo a liver transplant to survive.

Relevant Conferences:

4th International Conference on Hepatology April 27-28, 2017 Dubai, UAE 11th Global Gastroenterologists Meeting June 12-13, 2017 Rome, Italy, 5th World Congress on Hepatitis and Liver Diseases August 10-12, 2017 London, UK, 12th Euro-Global Gastroenterology Conference September 11-12, 2017 Paris, France, 2nd International Conference on Pancreatic Disorders and Treatment September 14-15, 2017 Dallas, USA, International Conference on Digestive Diseases October 16-18, 2017 Chicago, USA, 10th Global Congress on Gastroenterology and Endoscopy October 30-November 01, 2017 Bangkok, Thailand, 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA, German Association for the Study of the Liver, January 19-21, 2017 Essen, Germany, 10th Paris Hepatitis Conference January 30-31, 2017 Paris, France, EASL HCC Summit, February 02-05, 2017 Geneva, Switzerland, Belgian Week of Gastroenterology February 09-11, 2017 Antwerp, Belgium, Asian Pacific Digestive Week, Japan Digestive Disease Week, Paris Hepatitis Conference, World Congress on Gastroenterology.

Track 7: Liver Cancer

Liver cancer is also known as a hepatic cancer or which originates in the liver. Liver tumors have been discovered on medical imaging equipment (often by accident) symptomatically as an abdominal mass, abdominal pain, yellow skin and liver dysfunction. The leading cause of the liver cancer is cirrhosis which is caused due to either hepatitis B, hepatitis C, or alcohol.

Relevant Conferences:

4th International Conference on Hepatology April 27-28, 2017 Dubai, UAE 11th Global Gastroenterologists Meeting June 12-13, 2017 Rome, Italy, 5th World Congress on Hepatitis and Liver Diseases August 10-12, 2017 London, UK, 12th Euro-Global Gastroenterology Conference September 11-12, 2017 Paris, France, 2nd International Conference on Pancreatic Disorders and Treatment September 14-15, 2017 Dallas, USA, International Conference on Digestive Diseases October 16-18, 2017 Chicago, USA, 10th Global Congress on Gastroenterology and Endoscopy October 30-November 01, 2017 Bangkok, Thailand, 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA, German Association for the Study of the Liver, January 19-21, 2017 Essen, Germany, 10th Paris Hepatitis Conference January 30-31, 2017 Paris, France, EASL HCC Summit, February 02-05, 2017 Geneva, Switzerland, Belgian Week of Gastroenterology February 09-11, 2017 Antwerp, Belgium, Asian Pacific Digestive Week, Japan Digestive Disease Week, Paris Hepatitis Conference, World Congress on Gastroenterology.

Track 8: Other Liver Tumor

Liver tumors have been discovered on medical imaging equipment (often by accident) symptomatically as an abdominal mass, abdominal pain, yellow skin and liver dysfunction. The leading cause of the liver cancer is cirrhosis which is caused due to either hepatitis B, hepatitis C, or alcohol.

Relevant Conferences:

4th International Conference on Hepatology April 27-28, 2017 Dubai, UAE 11th Global Gastroenterologists Meeting June 12-13, 2017 Rome, Italy, 5th World Congress on Hepatitis and Liver Diseases August 10-12, 2017 London, UK, 12th Euro-Global Gastroenterology Conference September 11-12, 2017 Paris, France, 2nd International Conference on Pancreatic Disorders and Treatment September 14-15, 2017 Dallas, USA, International Conference on Digestive Diseases October 16-18, 2017 Chicago, USA, 10th Global Congress on Gastroenterology and Endoscopy October 30-November 01, 2017 Bangkok, Thailand, 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA, German Association for the Study of the Liver, January 19-21, 2017 Essen, Germany, 10th Paris Hepatitis Conference January 30-31, 2017 Paris, France, EASL HCC Summit, February 02-05, 2017 Geneva, Switzerland, Belgian Week of Gastroenterology February 09-11, 2017 Antwerp, Belgium, Asian Pacific Digestive Week, Japan Digestive Disease Week, Paris Hepatitis Conference, World Congress on Gastroenterology.

Track 9: Liver Diseases

Liver disease can be due to genetic or caused by a variety of factors that damage the liver, such as virus’s infection and consumption of alcohol. Liver damage is also associated with Obesity. Over time, damage to the liver has results in scarring (Liver cirrhosis), this can lead to liver failure, a life-threatening diseases. Liver disease is one of the top 10 causes of death in USA. There are more than 100 liver diseases. Some of the most common liver diseases are as follow.

Relevant Conferences:

4th International Conference on Hepatology April 27-28, 2017 Dubai, UAE 11th Global Gastroenterologists Meeting June 12-13, 2017 Rome, Italy, 5th World Congress on Hepatitis and Liver Diseases August 10-12, 2017 London, UK, 12th Euro-Global Gastroenterology Conference September 11-12, 2017 Paris, France, 2nd International Conference on Pancreatic Disorders and Treatment September 14-15, 2017 Dallas, USA, International Conference on Digestive Diseases October 16-18, 2017 Chicago, USA, 10th Global Congress on Gastroenterology and Endoscopy October 30-November 01, 2017 Bangkok, Thailand, 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA, German Association for the Study of the Liver, January 19-21, 2017 Essen, Germany, 10th Paris Hepatitis Conference January 30-31, 2017 Paris, France, EASL HCC Summit, February 02-05, 2017 Geneva, Switzerland, Belgian Week of Gastroenterology February 09-11, 2017 Antwerp, Belgium, Asian Pacific Digestive Week, Japan Digestive Disease Week, Paris Hepatitis Conference, World Congress on Gastroenterology.

Track 10: Other Metabolic Liver Disease

Liver is a gland which plays a major role in the metabolism with numerous functions in the human body, including the regulation of the glycogen storage, decomposition of the red blood cells, plasma protein synthesis, production of hormone and detoxification. Hepatocytes are the metabolic super achievers in the body which plays very critical roles in synthesizing the molecules that are been utilized elsewhere to support homeostasis and in converting molecules of one type to another in regulating the energy balances.

Relevant Conferences:

4th International Conference on Hepatology April 27-28, 2017 Dubai, UAE 11th Global Gastroenterologists Meeting June 12-13, 2017 Rome, Italy, 5th World Congress on Hepatitis and Liver Diseases August 10-12, 2017 London, UK, 12th Euro-Global Gastroenterology Conference September 11-12, 2017 Paris, France, 2nd International Conference on Pancreatic Disorders and Treatment September 14-15, 2017 Dallas, USA, International Conference on Digestive Diseases October 16-18, 2017 Chicago, USA, 10th Global Congress on Gastroenterology and Endoscopy October 30-November 01, 2017 Bangkok, Thailand, 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA, German Association for the Study of the Liver, January 19-21, 2017 Essen, Germany, 10th Paris Hepatitis Conference January 30-31, 2017 Paris, France, EASL HCC Summit, February 02-05, 2017 Geneva, Switzerland, Belgian Week of Gastroenterology February 09-11, 2017 Antwerp, Belgium, Asian Pacific Digestive Week, Japan Digestive Disease Week, Paris Hepatitis Conference, World Congress on Gastroenterology.

Track 11: Liver Fibrosis

Relevant Conferences:

4th International Conference on Hepatology April 27-28, 2017 Dubai, UAE 11th Global Gastroenterologists Meeting June 12-13, 2017 Rome, Italy, 5th World Congress on Hepatitis and Liver Diseases August 10-12, 2017 London, UK, 12th Euro-Global Gastroenterology Conference September 11-12, 2017 Paris, France, 2nd International Conference on Pancreatic Disorders and Treatment September 14-15, 2017 Dallas, USA, International Conference on Digestive Diseases October 16-18, 2017 Chicago, USA, 10th Global Congress on Gastroenterology and Endoscopy October 30-November 01, 2017 Bangkok, Thailand, 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA, German Association for the Study of the Liver, January 19-21, 2017 Essen, Germany, 10th Paris Hepatitis Conference January 30-31, 2017 Paris, France, EASL HCC Summit, February 02-05, 2017 Geneva, Switzerland, Belgian Week of Gastroenterology February 09-11, 2017 Antwerp, Belgium, Asian Pacific Digestive Week, Japan Digestive Disease Week, Paris Hepatitis Conference, World Congress on Gastroenterology.

Track 12: Liver Failure

Relevant Conferences:

4th International Conference on Hepatology April 27-28, 2017 Dubai, UAE 11th Global Gastroenterologists Meeting June 12-13, 2017 Rome, Italy, 5th World Congress on Hepatitis and Liver Diseases August 10-12, 2017 London, UK, 12th Euro-Global Gastroenterology Conference September 11-12, 2017 Paris, France, 2nd International Conference on Pancreatic Disorders and Treatment September 14-15, 2017 Dallas, USA, International Conference on Digestive Diseases October 16-18, 2017 Chicago, USA, 10th Global Congress on Gastroenterology and Endoscopy October 30-November 01, 2017 Bangkok, Thailand, 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA, German Association for the Study of the Liver, January 19-21, 2017 Essen, Germany, 10th Paris Hepatitis Conference January 30-31, 2017 Paris, France, EASL HCC Summit, February 02-05, 2017 Geneva, Switzerland, Belgian Week of Gastroenterology February 09-11, 2017 Antwerp, Belgium, Asian Pacific Digestive Week, Japan Digestive Disease Week, Paris Hepatitis Conference, World Congress on Gastroenterology.

Track 13: Pancreatitis

Pancreatitis is caused due to inflammation of the pancreas. The pancreas is the large organ present behind the stomach that produces digestive enzymes. Damage to the pancreas or biliary tract is caused due to infections, cancer, alcohol consumption, internal bleeding or obstruction.

Relevant Conferences:

4th International Conference on Hepatology April 27-28, 2017 Dubai, UAE 11th Global Gastroenterologists Meeting June 12-13, 2017 Rome, Italy, 5th World Congress on Hepatitis and Liver Diseases August 10-12, 2017 London, UK, 12th Euro-Global Gastroenterology Conference September 11-12, 2017 Paris, France, 2nd International Conference on Pancreatic Disorders and Treatment September 14-15, 2017 Dallas, USA, International Conference on Digestive Diseases October 16-18, 2017 Chicago, USA, 10th Global Congress on Gastroenterology and Endoscopy October 30-November 01, 2017 Bangkok, Thailand, 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA, German Association for the Study of the Liver, January 19-21, 2017 Essen, Germany, 10th Paris Hepatitis Conference January 30-31, 2017 Paris, France, EASL HCC Summit, February 02-05, 2017 Geneva, Switzerland, Belgian Week of Gastroenterology February 09-11, 2017 Antwerp, Belgium, Asian Pacific Digestive Week, Japan Digestive Disease Week, Paris Hepatitis Conference, World Congress on Gastroenterology.

Track 14: Pancreatic Cancer

Pancreatic cancer forms in the pancreas when the glandular organ located behind the stomach begin to multiply out of control and form a mass. These cancerous cells have the ability to destroy other parts of the body. There are number of types of pancreatic cancer.

Relevant Conferences:

4th International Conference on Hepatology April 27-28, 2017 Dubai, UAE 11th Global Gastroenterologists Meeting June 12-13, 2017 Rome, Italy, 5th World Congress on Hepatitis and Liver Diseases August 10-12, 2017 London, UK, 12th Euro-Global Gastroenterology Conference September 11-12, 2017 Paris, France, 2nd International Conference on Pancreatic Disorders and Treatment September 14-15, 2017 Dallas, USA, International Conference on Digestive Diseases October 16-18, 2017 Chicago, USA, 10th Global Congress on Gastroenterology and Endoscopy October 30-November 01, 2017 Bangkok, Thailand, 13th International Conference on Clinical Gastroenterology and Hepatology, November 13-15, 2017 Las Vegas, USA, German Association for the Study of the Liver, January 19-21, 2017 Essen, Germany, 10th Paris Hepatitis Conference January 30-31, 2017 Paris, France, EASL HCC Summit, February 02-05, 2017 Geneva, Switzerland, Belgian Week of Gastroenterology February 09-11, 2017 Antwerp, Belgium, Asian Pacific Digestive Week, Japan Digestive Disease Week, Paris Hepatitis Conference, World Congress on Gastroenterology.

Track 15 : Hepatology Executive Meet

Hepatology Executive Meet is a global platform aimed to connect Entrepreneurs, Proposers and the Investors worldwide. It intended to create and facilitate the most optimized and viable business meeting place for engaging people in to constructive discussions, evaluation and execution of promising business ideas. An investor could be able to find out the highest potential investment opportunities, which provide good return on investment. For entrepreneurs, this would be an ideal place to find out suitable investors and partners to start or expand their business.

 





Market Analysis

Summary

Hepatology is the branch of medical sciences which deals with the path logistic study, prevention and management of diseases of liver, gall bladder, biliary tree and pancreas. Some of the cases in hepatology include jaundice, liver cancer, liver transplantation, drug overdose, pancreatitis, GIT bleeding, bilary infection bleeding etc. Hepatology represent a growing problem for the international health care systems and, first of all, for the patients. Alcoholism and resulting alcoholic liver disease is the an important factor in some Asian countries as well as in most industry countries but here the fastest growing segment in hepatology is NASH (non-alcoholic steatohepatitis). NASH is the most severe form of NAFLD, the major cause of cryptogenic liver cirrhosis. Nearly 10% of the US Americans (25 Million) are afflicted with liver-related diseases each year. Chronic liver diseases are the biggest problem. An estimated 30% of the world's total population (2 billion) has been infected with hepatitis B virus and more than 350 million people (perhaps 400) are Inflicted by chronic HBV. About 170 million persons have hepatitis C. The global liver disease therapeutics market totalled $24.5 billion in 2014, with the U.S. contributing $9.1 billion, and is anticipating a global market of $33.8 billion by 2019, according to a press release.

Importance and Scope

This conference will encourage innovative ideas and advanced diagnostic approaches towards the liver disease. It will share recent advancements and knowledge share about liver and pancreatic diseases and treatment strategies. The participant companies can display their product to gain the networks and to promote their upcoming new strategies for the future era.

The main aim of this conference is to gather Hepatologists, Gastroenterologists, Pathologists, Directors/CEO & Industry experts, Professors, Researchers, Scientists and Students of Hepatology and Liver diseases in all areas of Liver diseases & Therapeutics and to provide an international forum for the dissemination of original research results, new ideas and practical development experiences related to the research.

Major Hepatology Associations around the Globe

Emirates Gastroenterology and Hepatology Society (EGHS)

European Association for the Study of the Liver

The International Association for the Study of the Liver

The Saudi Society of Pediatric Gastroenterology, Hepatology and Nutrition (SASPGHAN)

The Pan Arab society of Pediatric Gastroenterology, Hepatology and Nutrition (PASPGHAN))

The Japan Society of Hepatology

The Egyptian Society of Hepatology, Gastroenterology and Infectious Diseases in Alexandria (ESHGID)

The Egyptian Hepato-Pancreato-Biliary Society

Hepatology Society of the Philippines

Top Medical University in Dubai

Gulf Medical University

RAK Medical and Health Sciences University

Royal College of Surgeons in Ireland (Dubai)

Harvard Medical School for Global Health Delivery – Dubai

Dubai Medical College

Dubai Pharmacy College

University of Sharjah

Pharmaceutical Companies in UAE-Dubai

Elis Pharmaceuticals Limited 

Alliance Global

Sanofi Aventis UAE  

Genpharm

Ranbaxy Laboratories Limited          

BioPharma

GlaxoSmithKline       

Gulf Inject

Saga Pharmaceuticals 

Global Pharma

Astra Zeneca UAE    

Neopharma

Baxter A.G    

Medpharma

Gilead Sciences, Inc.

BIOPHARMA-MEA





Past Conference Report

Hepatology 2016

2nd International Conference on Hepatology (Hepatology-2016) organised by Conference Series LLC took place at Double Tree by Hilton Hotel Chicago - North Shore, Chicago, USA during May 09-11, 2016. The conference highlighted the theme, “To discuss and share the latest updates and cutting-edge technologies in the field of Hepatology”. It is an annual meeting for the study of Liver and Pancreatic diseases.

We successfully hosted Hepatology 2016 conference with the support and contribution of the organizing committee members. The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates driving the three days event into the path of success with thought provoking keynote and plenary presentations. Active participation and generous response were received from the Organizing Committee Members and Editorial Board Members of OMICS International Journals. Professors, Researchers, and Students from diverse groups made this conference as one of the most successful and productive event in 2016 from Conference Series LLC.

The conference was initiated with a warm welcome note from Honorable guests and the Keynote forum lead by Dr. David Van Thiel, Rush University Medical Center, USA followed by Dr. Trent W Nichols, AMRI, USA. Our special thanks to Dr. Eve Isabelle Pecheur, Cancer Research Center of Lyon, France and Dr. Sumathi Ramachandran, Centers for Disease Control and Prevention, USA, the Honorable Moderators for the conference who contributed a major part for the success of this event.

The highlights of the meeting were the enlightening keynote lectures from:

  • Dr. David Van Thiel, Rush University Medical Center, USA on the topic, “Endocan a valuable biomarker for Hepatocellular Carcinoma (HCC)”.
  • Dr. Trent W Nichols, AMRI, USA on the topic, “Wnt signaling in hepatocellular carcinoma, an emerging epidemic: Gene up regulation of Wnt 5a pathways with toll receptor 4 with moderated magnetic fields on human stem cells and mice and high dose vitamin D3 prevention”.
  • Mark A Feitelson, Temple University, USA on the topic, “Symbiotic bacteria provide chemoprevention against hepatitis B virus mediated hepatocellular carcinoma in hepatitis B x transgenic mice”.
  • Eve-Isabelle Pecheur, Cancer Research Center of Lyon, France on the topic, “Hepatitis C virus infection: A subtle but toxic combination of lipids, proteins and sugars”.
  • Anil Kaul, Oklahoma State University, USA on the topic, “Microflora and TLRs in HCV-related cirrhosis and hepatocellular carcinoma”.

The conference proceedings were carried out through various scientific sessions and plenary lectures:

  • Title: Chronic Hepatitis Delta Virus (HDV) infection: What do we need to know? by Raffaella Romeo, University of Milan, Italy.
  • Title: Incidence of the hepatitis C in prison in France: Results of a study by POCT presented by André-Jean Remy, Perpignan Hospital, France.
  • Title: Hepatitis C Virus (HCV) genotype 1b as a risk factor for hepatocellular carcinoma development in chronic HCV positive patients in Southern Italy presented by Arnolfo Petruzziello, IRCCS, Italy.
  • Title: Connexins and pannexins as novel drug targets in the treatment of acute and chronic liver disease lectured by Mathieu Vinken, Free University Brussels, Belgium.
  • Title: Hepatitis B and C care in the opiate substitution setting-An integrated nursing model of care delivered by Vince Fragomeli, Nepean Hospital, Australia.
  • Title: Using NUCs in prevention of mother-to-child transmission of HBV: To treat or not to treat? given by Yuming Wang, Third Military Medical University, China.
  • Title: Hepatitis outbreaks and surveillance: Advanced molecular detection and beyond presented by Sumathi Ramachandran, Centers for Disease Control and Prevention, USA.
  • Title: The regulation and functional roles of the HCV NS5A-stabilizing factor, Y-Box binding protein 1, in HCV life cycle shared by Wei-Ting Wang, National Chiao-Tung University, Taiwan.
  • Title: Hepatitis B virus in Cote d Ivoire (West Africa) lectured by Alphonsine Kouassi-M Bengue, University Felix Houphouet Boigny, Cote d Ivoire.
  • Title: Epidemiological characteristics of hepatocellular carcinoma in Egypt: A retrospective analysis of 1313 cases shared by Mohammed Omar Khalifa, Ain Shams University School of Medicine, Egypt.
  • Title: Anticancer activity of Aloe vera and Calligonum comosum extracts separately on hepatocellular carcinoma cells given by Mahmoud M Zakaria Ibrahim, Mansoura University, Egypt.
  • Title: HCV diagnosis in China by Bingshui Xiu, Beijing Institute of Basic Medical Sciences, China.

Conference Series LLC has taken the privilege of felicitating Hepatology 2016 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. Conference Series LLC, congratulate the Best Poster awardee Md Kamrul Hasan Chowdhury, University of New South Wales, Australia.

We are glad to inform that all accepted abstracts for the conference have been indexed in OMICS International Journal, Journal of Liver as a special issue.

We sincerely thank the Organizing Committee Members, Editorial Board Members of OMICS International Journals, Participants, Attendees and Media Partners for their gracious presence and generous support, without which the conference would not have reached the pinnacle of success. With the unique feedback from the conference, Conference Series LLC would like to announce the commencement of the “3rd World Congress on Hepatitis and Liver Diseases” during October 10-12, 2016 in Dubai, UAE and “4th International Conference on Hepatology” during May 04-06, 2017 in Dubai, UAE.

Let us meet again @ Hepatitis 2016 & Hepatology 2017


Past Reports  Gallery  



Past Conference Report

Hepatitis 2015

OMICS International takes a great pride in announcing the commencement of "World Congress on Hepatitis” during July 20-22, 2015 at Hyatt Regency Orlando International Airport, Florida, USA. The conference highlights the theme “Raising global awareness on hepatitis and fighting the stigma surrounding the disease”. It is the annual meeting for the study of Hepatitis.

With the support and contribution of the organizing committee members, we successfully hosted an event at the conference venue. Active participation and generous response were received from the Organizing Committee Members, Editorial Board Members of OMICS Group Journals, Professors, Researchers, Experts and Students from diverse groups who made this conference as one of the most successful and productive event in 2015 from OMICS International. The conference was marked with the attendance of young researchers, business delegates and students who have driven this event into the path of success.  

The conference was initiated with a warm welcome note from Honorable guests and the Keynote forum lead by Dr. Mark A Feitelson, Associate Director, Temple University, USA. The proceedings went through interactive sessions and panel discussions headed by Dr. Trent W Nichols, AMRI, USA, an honorable Moderator for the conference, who contributed a major part for the success of this event. The event offers a best platform with its well organized scientific program to the audience on the topics Hepatitis Care and Cure, Diagnosis & Liver Pathology/ Case Studies, Assessment of Liver Diseases, Liver  cancer and Hepatocellular carcinoma, Advanced Management of Liver diseases, Clinical Liver Transplantation and Liver Surgery, Advancement in new drug discovery for treatment of hepatitis, Advance Technologies for the treatment of hepatitis and Liver diseases, Current research in Hepatology.

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of hepatitis, carried out through various scientific-sessions and plenary lectures:

  • Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? -Dr. Mark A Feitelson, Temple University, USA
  • The Growing Epidemic in HCC from Hepatitis/NASH Cirrhosis in American Veterans-Dr. Trent W Nichols, AMRI, USA
  • Lower GI Bleeding in Patients with cirrhosis- Dr. Maxwell M Chait, Columbia University, USA
  • Impacts of platelets on the prognosis of patients with hepatocellular carcinoma– Dr. Sen-Yung Hsieh, Chang Gung Memorial Hospital, Taiwan

Also, the conference proceeding was encouraged through the wonderful symposiums by Dr. Andre Jean Remy, Perpignan Hospital, France, on the title ” New tools of screening viral hepatitis in real life: The French model of care and by Dr. Ehab Abd-El-Atty, Menoufia University, Egypt, on the title “HCC risk factors synergism in Egypt and how to prevent?”

A workshop session was done on “The Cirrhosis Micro-environment and Hepato-carcinogenesis” by Dr. Sen-Yung Hsieh, Chang Gung Memorial Hospital, Taiwan.

OMICS International has taken the privilege of felicitating Hepatitis-2015 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. OMICS International, on behalf of the conference exhibitor congratulate the Best Poster awardee for her outstanding performance in the field of Hepatocellular carcinoma and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors. 

We are glad to inform that all accepted abstracts for the conference have been indexed in OMICS Journal of Liver and Journal of Liver Disease and Transplantation as a special issue.

We sincerely thank the Organizing Committee Members, Editorial Board Members of OMICS Journals, Participants, Attendees, Sponsors, Exhibitors, and Media partners for their gracious presence and generous support, without which the conference would not have been possible. With the unique feedback from the conference, OMICS International would like to announce the commencement of the "2nd International Conference on Hepatology” May 9-11, 2016 in Chicago, USA and “3rd World Congress on Hepatitis and Liver Diseases" October 17-19, 2016 in Dubai, UAE.

 

Let us meet again @ 2016 Conferences


Past Reports  Gallery  



Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date April 27-28, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2 Day 3
Poster Opportunity Available

Testimonials

Conferenceseries Destinations